TriplePoint Venture Growth BDC Corp.

NYSE (USD): TriplePoint Venture Growth BDC Corp. (TPVG)

Last Price

7.66

Today's Change

+0.04 (0.52%)

Day's Change

7.60 - 7.71

Trading Volume

346,122

Overview

Market Cap

306 Million

Shares Outstanding

40 Million

Avg Volume

413,274

Avg Price (50 Days)

7.53

Avg Price (200 Days)

8.14

PE Ratio

38.30

EPS

0.20

Earnings Announcement

04-Mar-2025

Previous Close

7.62

Open

7.65

Day's Range

7.6 - 7.71

Year Range

6.441 - 11.58

Trading Volume

341,098

Price Change Highlight

1 Day Change

0.52%

5 Day Change

5.66%

1 Month Change

-8.37%

3 Month Change

12.15%

6 Month Change

-4.61%

Ytd Change

0.52%

1 Year Change

-31.55%

3 Year Change

-57.61%

5 Year Change

-46.88%

10 Year Change

-48.45%

Max Change

-51.05%

News and Blogs

No result.

Company Profile

Sector: Financial Services - Financial Services

Industry: Asset Management

Description:

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment